Martins e Silva Benedito, Rêgo Lerika Moreira, Galvão Márcio Almeida, Florêncio Telma Maria de Menezes Toledo, Cavalcante Jairo Calado
Faculdade de Medicina, Universidade Federal de Alagoas, Maceió, AL, Brazil.
Rev Col Bras Cir. 2013 May-Jun;40(3):196-202. doi: 10.1590/s0100-69912013000300006.
To assess the prevalence of sexual dysfunction in obese and overweight patients treated at the Professor Alberto Antunes University Hospital (HUPAA - UFAL).
This is a descriptive study. The sample consisted of overweight or obese females. Anthropometric data were collected for assessment of body mass index (BMI) and waist circumference (WC). In all subjects we measured the levels of blood glucose, total cholesterol and triglycerides. We applied a Portuguese-validated version of the Female Sexual Function Index (FSDI), which assesses sexual response as for desire, arousal, vaginal lubrication, orgasm, sexual satisfaction and pain. The total score is the sum of scores for each domain multiplied by the corresponding factor and can vary from '2 'to '36', a total score less than or equal to '26 ' being considered risky for sexual dysfunction.
We evaluated 23 women with a mean age of 44, where 73.9% were obese and 82.6% had a highly increased risk for metabolic complications (WC e" 88 cm). The increased risk for sexual dysfunction was present in 78.3% of the interviewees, causing biopsychosocial impairment. Hypertension, diabetes and dyslipidemia were present in 33.3%, 22.2% and 61.1%, respectively, of patients at risk for sexual dysfunction.
The analysis of the results demonstrates the need for better research and attention of physicians to patients with obesity or overweight.
评估在阿尔贝托·安图内斯教授大学医院（HUPAA - UFAL）接受治疗的肥胖和超重患者性功能障碍的患病率。
这是一项描述性研究。样本包括超重或肥胖女性。收集人体测量数据以评估体重指数（BMI）和腰围（WC）。在所有受试者中，我们测量了血糖、总胆固醇和甘油三酯水平。我们应用了葡萄牙语验证版的女性性功能指数（FSDI），该指数评估性欲、性唤起、阴道润滑、性高潮、性满意度和疼痛等性反应。总分是每个领域得分乘以相应因子的总和，范围从“2”到“36”，总分小于或等于“26”被认为有性功能障碍风险。
我们评估了23名平均年龄为44岁的女性，其中73.9%为肥胖，82.6%有代谢并发症高风险（WC≥88 cm）。78.3%的受访者存在性功能障碍风险增加，导致生物心理社会损害。有性功能障碍风险的患者中，高血压、糖尿病和血脂异常的发生率分别为33.3%、22.2%和61.1%。
结果分析表明需要更好地开展研究，医生也需要更多关注肥胖或超重患者。
